NVAX — Novavax Cashflow Statement
0.000.00%
Last trade - 00:00- $572.41m
- $232.98m
- $983.71m
- 15
- 43
- 21
- 16
Annual cashflow statement for Novavax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -133 | -418 | -1,744 | -658 | -545 |
| Depreciation | |||||
| Non-Cash Items | 14.4 | 359 | 320 | 574 | 167 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -24 | 12 | 1,734 | -361 | -377 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -137 | -42.5 | 323 | -416 | -714 |
| Capital Expenditures | -1.86 | -54.6 | -57.5 | -93 | -53.8 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 40.3 | -323 | 158 | 0 | -5.04 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | 38.5 | -378 | 100 | -93 | -58.8 |
| Financing Cash Flow Items | — | -39.1 | — | -5.26 | -3.59 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 98.4 | 985 | 462 | 325 | 4.47 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.221 | 567 | 880 | -179 | -765 |